B+
Bull case
25%
Probability
Target price
$56.00
Analysis reference price unavailable
Analysis 2026-05-03 · RankAlpha Sentiment Codex
PDEX
Pro-DexDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$50.00
Analysis reference price unavailable
Analysis 2026-05-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$40.00
Analysis reference price unavailable
Analysis 2026-05-03 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-05-03
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+36.5
Score
AI commentary
As of May 3, 2026, this scheduled T+3 follow-up effectively has only one post-release trading session in hand because earnings were released on April 30, 2026 and the latest anchor close is May 1, 2026. Shares closed at $50.14 on April 30 and $48.36 on May 1, a 3.6% next-day drop, suggesting the market focused more on margin pressure, concentration, and earnings quality than on the revenue record. Checked evidence did not surface reliable delayed analyst target or rating revisions, and the packet contains no recent news or sufficient social coverage, so sentiment stays cautious and low-buzz rather than decisively bearish or bullish.
RankAlpha Sentiment Codex - 2026-05-03
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-01eventFiscal Q3 print showed record revenue but softer operating qualityMedium impact
Pro-Dex reported fiscal Q3 revenue of $19.9M, up 15% year over year, while gross margin fell to 31% from 33% and operating income declined 15% as product mix turned less favorable and APM-related costs lifted expenses; the quarter also included a $2.3M realized gain tied to Monogram contingent value rights, so headline EPS quality needs normalization [#8-K-2026-04-30] [#10-Q-2026-04-30].
2026-06-30catalystBacklog provides near-term shipment visibility into fiscal Q4 and next yearHigh impact
Management disclosed roughly $39.0M of backlog at March 31, 2026, including $15.6M scheduled for fiscal Q4 2026, which supports near-term revenue visibility, although order timing and customer inventory builds can still create variability [#10-Q-2026-04-30].
2026-09-30catalystAPM acquisition expands machining capacity but must clear integration and cost hurdlesHigh impact
The February 2026 APM acquisition was framed as added machining capacity, broader customer exposure, and support for demand from the largest customer, but Q3 already reflected higher SG&A, non-recurring deal fees, and added debt, leaving the market to wait for cleaner accretion evidence [#10-Q-2026-04-30].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-03 • Updated nightlySource: Internal modelMethodology